Freya Biosciences ApS

https://www.freyabiosciences.com

LinkedIn: https://www.linkedin.com/company/freya-biosciences

Freya Biosciences is a clinical-stage biotech company with headquarters in Copenhagen, Denmark and Boston, Massachusetts dedicated to reimagining women's health and redefine fertility for those previously deprived of options. With a focus on microbial immunotherapies, Freya addresses immune drivers underlying a range of reproductive health conditions to create a future where everyone is empowered with optimal reproductive health. *

	Start	2023-12-12 existent
	Industry	microbial therapy
	Industry 2	women’s health
	Person	Acosta, Colleen (Freya Biosciences 20231212 CEO + Co-Founder)

	Region	København (Copenhagen)
	Country	Denmark
	Street	3 Fruebjergvej
	City	2100 København
		Address record changed: 2023-12-19

Basic data	Employees	n. a.

		* Document for »About Section«: Freya Biosciences. (12/12/23). "Press Release: Freya Biosciences Announces $38 Million Funding in One of the Largest Series A Raises to Advance Women’s Reproductive Immunotherapies". Copenhagen.

		Record changed: 2024-03-24

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for Freya Biosciences ApS

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)